Difference between revisions of "Sirolimus (Rapamune)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Hodgkin lymphoma" to "Classical Hodgkin lymphoma") |
m (→Also known as) |
||
Line 12: | Line 12: | ||
==Also known as== | ==Also known as== | ||
− | *'''Code names:''' AY 22989, SILA 9268A, SLM, WY-090217 | + | *'''Code names:''' AY-22989, SILA-9268A, SLM, WY-090217 |
*'''Generic names:''' RAPA, rapamycin | *'''Generic names:''' RAPA, rapamycin | ||
*'''Brand name:''' Rapamune | *'''Brand name:''' Rapamune |
Revision as of 12:08, 19 August 2023
Mechanism of action
From the NCI Drug Dictionary: A natural macrocyclic lactone produced by the bacterium Streptomyces hygroscopicus, with immunosuppressant properties. In cells, sirolimus binds to the immunophilin FK Binding Protein-12 (FKBP-12) to generate an immunosuppressive complex that binds to and inhibits the activation of the mammalian target of rapamycin (mTOR), a key regulatory kinase. This results in inhibition of T lymphocyte activation and proliferation that occurs in response to antigenic and cytokine (IL-2, IL-4, and IL-15) stimulation and inhibition of antibody production.
Diseases for which it is used
Diseases for which it was used
Also known as
- Code names: AY-22989, SILA-9268A, SLM, WY-090217
- Generic names: RAPA, rapamycin
- Brand name: Rapamune